ISOLATE II RNA Micro Kit

RNA isolation / purification Cells - primary human carotid artery endothelial cells

Experiment
RNA isolation / purification Cells - primary human carotid artery endothelial cells
Product
ISOLATE II RNA Micro Kit from Bioline
Manufacturer
Bioline

Protocol tips

Upstream tips
- This kit can be used for the isolation of RNA from up to 1x10^6 cells

Publication protocol

Total RNA was isolated using a commercial kit (Total mRNA Isolate II Mini Kit, Bioline (Sydney, Australia).

Full paper   Login or join for free to view the full paper.

Reviews

ISOLATE II RNA Micro Kit from Bioline has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Discussion

2 years ago

Author: Switzerland

I am having trouble using the QiageN RNAeasy mini kit for CD34+ cells. Any tips?

I am having trouble using the QiageN RNAeasy mini kit for CD34+ cells. Any tips?

Share your thoughts or question with experts in your field by adding a discussion!

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing RNA isolation / purification Cells - primary human carotid artery endothelial cells using ISOLATE II RNA Micro Kit from Bioline.

Paper title
Serum Amyloid A Receptor Blockade and Incorporation into High-Density Lipoprotein Modulates Its Pro-Inflammatory and Pro-Thrombotic Activities on Vascular Endothelial Cells
Full paper
Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from Bioline for ISOLATE II RNA Micro Kit below.

Download PDF Download manufacturer protocol

Videos

Check out videos that might be relevant for performing RNA isolation / purification Cells - primary human carotid artery endothelial cells using ISOLATE II RNA Micro Kit from Bioline. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Become shareholder Discussions About us Contact Privacy Terms